Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03523455 · ClinicalTrials.gov registry record · NA

Iron Aid IPS on Performance, Fatigue and Iron Levels During 12 Weeks of Supplementation and Aerobic Training

A NA study, sponsored by University of Mary Hardin-Baylor.

Terminated
Registry status
NA
Development phase
2
Enrollment target

NCT03523455 is a NA study that was terminated before completion, run by University of Mary Hardin-Baylor. The registered enrollment target is 2 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03523455, a NA study, was terminated before completion, sponsored by University of Mary Hardin-Baylor.

TERMINATED
Registry status
NA
Development phase
2 participants
Enrollment target

Study Summary

Participants are required to undergo a screening and qualification before beginning the study. Once qualified, baseline testing is completed in the laboratory. This testing includes: body composition measurements, a blood draw, questionnaires, a VO2 max test, and a time to exhaustion trial. This testing is repeated during week 4 and week 12. At week 8, subjects complete a blood draw and questionnaires only. During the 12 week period, participants will follow an endurance exercise program in which they will train 4 days per week. This is a double-blind study in which participants are randomized into either the placebo or supplement group. They are instructed to ingest the supplement once a day at breakfast. Diet logs are also monitored throughout the duration of the study with the restriction of no red meat.

Interventions

  • OTHER Sugar Pill
  • DIETARY_SUPPLEMENT Iron Aid IPS (Iron Protein Succinylate)

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2016-11-29
Est. Completion 2017-11-11
Phase NA

Sponsor

University of Mary Hardin-Baylor

10 total trials

What the Registry Record Tells You About NCT03523455

The ClinicalTrials.gov registry entry for NCT03523455 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Mary Hardin-Baylor, which has 10 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Sugar Pill is the first listed.

NCT03523455 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03523455 about?

NCT03523455 is a clinical study titled "Iron Aid IPS on Performance, Fatigue and Iron Levels During 12 Weeks of Supplementation and Aerobic Training". Participants are required to undergo a screening and qualification before beginning the study. Once qualified, baseline testing is completed in the laboratory. This testing includes: body composition measurements, a blood draw, questionnaires, a VO2 max test, and a time to exhaustion trial. This tes...

What is the current status of trial NCT03523455?

This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2016-11-29. Estimated completion is 2017-11-11.

What interventions are being tested in trial NCT03523455?

The interventions under investigation include: Sugar Pill (OTHER), Iron Aid IPS (Iron Protein Succinylate) (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03523455?

This trial is sponsored by University of Mary Hardin-Baylor, which has 10 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.